What opioids are contraindicated in patients with End-Stage Renal Disease (ESRD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Opioids Contraindicated in End-Stage Renal Disease (ESRD)

Morphine, codeine, meperidine, and tramadol are contraindicated in patients with ESRD due to the accumulation of toxic metabolites that can cause neurotoxicity. 1

Contraindicated Opioids in ESRD

Absolutely Contraindicated:

  • Morphine: Contraindicated due to accumulation of morphine-6-glucuronide, an active metabolite that contributes to analgesia but can worsen adverse effects in patients with renal insufficiency 2, 1
  • Codeine: Should be avoided due to accumulation of toxic metabolites 1, 3
  • Meperidine: Contraindicated due to accumulation of normeperidine, which can cause neurotoxic reactions with myoclonus and convulsions in patients with renal failure 2, 1, 4
  • Propoxyphene: Contraindicated in chronic pain, especially in patients with impaired renal function, as accumulation of renally cleared metabolites may result in neurotoxicity or cardiac arrhythmias 2

Not Recommended:

  • Tramadol: Not recommended in ESRD due to metabolite accumulation 1, 3

Safe Opioid Alternatives for ESRD Patients

First-Line Options:

  • Fentanyl: Preferred option due to minimal renal clearance and lack of active metabolites 1, 3, 5
  • Buprenorphine: Safer alternative with minimal renal metabolism 1, 3, 5

Second-Line Options (Use with Caution):

  • Hydromorphone: Can be used with significant dose reduction (25-50% of normal dose) and extended dosing intervals 1, 3
  • Methadone: Can be used with caution, but only by clinicians experienced with its complex pharmacokinetics 1, 5

Important Considerations for Pain Management in ESRD

  1. Dose Adjustments:

    • Start with significantly lower doses (25-50% of normal dose)
    • Extend dosing intervals
    • Titrate slowly based on response and side effects 1
  2. Monitoring:

    • Monitor more frequently for signs of opioid toxicity including myoclonus, hyperalgesia, and delirium
    • Watch for side effects such as constipation and nausea 1
  3. Non-Opioid Alternatives:

    • Acetaminophen is the safest first-line analgesic option (500-650 mg every 8-12 hours) 1
    • Gabapentin for neuropathic pain (100 mg after each dialysis session) 1
    • Topical agents like lidocaine 5% patch for localized pain 1
  4. Avoid NSAIDs:

    • NSAIDs are contraindicated in ESRD patients due to risk of worsening renal function 1

Common Pitfalls and Caveats

  • Undertreatment: Pain is often undertreated in ESRD patients due to concerns about medication safety 3, 5
  • Metabolite Accumulation: The primary concern with opioids in ESRD is the accumulation of metabolites that can cause neurotoxicity 4, 6
  • Dialysis Considerations: Medication timing should be adjusted based on dialysis schedule to prevent removal of certain medications during dialysis 1
  • Constipation Management: Proactively address constipation with stimulant or osmotic laxatives as opioids can worsen this common problem in ESRD patients 1

Remember that effective pain management in ESRD patients requires careful selection of appropriate opioids, proper dose adjustments, and vigilant monitoring for adverse effects.

References

Guideline

Pain Management in Patients with End-Stage Renal Disease on Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of pain in end-stage renal disease patients: Short review.

Hemodialysis international. International Symposium on Home Hemodialysis, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.